We are live on ! Find out more
Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Portfolio holdings

AUM $59.8B
1-Year Est. Return 29.42%
This Fund
S&P 500
This Quarter Est. Return
+2.55%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$73.7B
AUM Growth
+$7.59B
Cap. Flow
+$5.52B
Cap. Flow %
7.49%
Top 10 Hldgs %
25.26%
Holding
3,840
New
264
Increased
2,051
Reduced
1,186
Closed
193

Sector Composition

Rank Sector Weight
1 Technology 16.15%
2 Financials 6.29%
3 Industrials 4.43%
4 Healthcare 4.03%
5 Consumer Discretionary 3.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKYO
3576
OKYO Pharma
OKYO
$78.2M
$21.2K ﹤0.01%
10,000
ACH
3577
Accendra Health
ACH
$214M
$21.1K ﹤0.01%
+11,048
New +$39.5K
SGMO
3578
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$20.1K ﹤0.01%
45,300
+35,000
+340% +$18.6K
SSYS icon
3579
Stratasys
SSYS
$774M
$17.5K ﹤0.01%
665
+200
+43% +$1.98K
HIPO icon
3580
Hippo Holdings
HIPO
$861M
$17K ﹤0.01%
292
+83
+40% +$2.77K
SPXS icon
3581
CALL
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$332M
$16.8K ﹤0.01%
48,000
-48,000
-50% -$1.76M
KOS icon
3582
Kosmos Energy
KOS
$1.48B
$16.6K ﹤0.01%
16,613
-6,468
-28% -$8.53K
CRDL
3583
Cardiol Therapeutics
CRDL
$164M
$16.6K ﹤0.01%
16,552
-218
-1% -$228
DXLG icon
3584
Destination XL Group
DXLG
$35.4M
$16.1K ﹤0.01%
18,191
-51
-0.3% -$52
CGEN icon
3585
Compugen
CGEN
$228M
$16K ﹤0.01%
+10,313
New +$17.1K
LXRX icon
3586
Lexicon Pharmaceuticals
LXRX
$1.1B
$15.4K ﹤0.01%
13,520
-5,357
-28% -$7.36K
FAZ
3587
CALL
Direxion Daily Financial Bear 3x ETF
FAZ
$86.7M
$15.2K ﹤0.01%
40,000
-40,000
-50% -$1.68M
CGTX icon
3588
Cognition Therapeutics
CGTX
$96.7M
$14.1K ﹤0.01%
10,000
-1,000
-9% -$1.62K
INVZ icon
3589
Innoviz Technologies
INVZ
$112M
$11.9K ﹤0.01%
10,109
BRCC icon
3590
BRC Inc
BRCC
$250M
$11.7K ﹤0.01%
11,158
-3,741
-25% -$4.85K
HUMA icon
3591
Humacyte
HUMA
$194M
$11K ﹤0.01%
10,140
-3,460
-25% -$4.9K
RZLV
3592
CALL
Rezolve AI
RZLV
$1.09B
$10.8K ﹤0.01%
+10,000
New +$37.7K
CGNT icon
3593
Cognyte Software
CGNT
$680M
$8.22K ﹤0.01%
+123
New +$1.06K
FLG
3594
CALL
Flagstar Bank National Association
FLG
$5.82B
$8.05K ﹤0.01%
13,500
-1,000
-7% -$12K
OPY icon
3595
Oppenheimer Holdings
OPY
$1.2B
$6.22K ﹤0.01%
81
ALGS icon
3596
Aligos Therapeutics
ALGS
$34.9M
0
OPFI icon
3597
OppFi
OPFI
$803M
$2.54K ﹤0.01%
851
-31
-4% -$314
SHW icon
3598
PUT
Sherwin-Williams
SHW
$89.8B
$2.29K ﹤0.01%
14,866
-3,819
-20% -$1.28M
ASTLW icon
3599
Algoma Steel Group Warrant
ASTLW
$2.15K ﹤0.01%
30,000
AAPL icon
3600
PUT
Apple
AAPL
$4.57T
-116,675
Closed -$584K

Similar funds

Wealth Enhancement Advisory Services's Q4 2025 Portfolio in Review

As of Q4 2025, Wealth Enhancement Advisory Services held 3,840 positions worth $73.7B, up 11% from $66.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Wealth Enhancement Advisory Services deployed $5.52B of net new capital in Q4 2025, opening 264 new positions and adding to 2,051 existing holdings. Its largest new stake was FIS Bright Portfolios Focused Equity ETF: 3,197,675 shares worth $97.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Accenture, an estimated $127M trimmed.

  • Wealth Enhancement Advisory Services's largest Q4 2025 buy was FIS Bright Portfolios Focused Equity ETF: 3,197,675 shares worth $97.2M.
  • Wealth Enhancement Advisory Services added most to Broadcom in Q4 2025, an estimated $2.53B increase.
  • Wealth Enhancement Advisory Services's biggest Q4 2025 reduction was Accenture, cutting an estimated $127M.
  • Wealth Enhancement Advisory Services fully exited iShares iBonds Dec 2025 Term Treasury ETF in Q4 2025, selling an estimated $13.2M.
  • Wealth Enhancement Advisory Services's ten largest holdings make up 25% of its $73.7B portfolio in Q4 2025.
  • Wealth Enhancement Advisory Services opened 264 new positions and closed 193 in Q4 2025.
  • Wealth Enhancement Advisory Services's portfolio value rose 11% quarter-over-quarter to $73.7B.

Based on Wealth Enhancement Advisory Services's 13F filing for Q4 2025, filed 8 Jan 2026.